Marmojada, Baby Girl .
HRN: 29-12-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/06/2026
06/13/2026
IVT
44mg
Q24
PSNB (Maternal UTI)
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: